Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction.

Barrett TD, Yan W, Freedman JM, Lagaud GJ, Breitenbucher JG, Shankley NP.

Br J Pharmacol. 2008 Apr;153(8):1650-8. doi: 10.1038/bjp.2008.44. Epub 2008 Feb 25.

PMID:
18297100
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.

Morton MF, Barrett TD, Yan W, Freedman JM, Lagaud G, Prendergast CE, Moreno V, Pyati J, Figueroa K, Li L, Wu X, Rizzolio M, Breitenbucher JG, McClure K, Shankley NP.

J Pharmacol Exp Ther. 2007 Nov;323(2):562-9. Epub 2007 Aug 7.

PMID:
17684117
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis.

Latorre M, Bartolomé-Nebreda JM, García-López MT, González-Muñiz R, Herranz R, Del Río J, Cenarruzabeitia E.

Pharmacology. 2004 Oct;72(2):68-76.

PMID:
15331911
[PubMed - indexed for MEDLINE]
5.

Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.

Taniguchi H, Yomota E, Kume E, Shikano T, Endo T, Nagasaki M.

Jpn J Pharmacol. 1997 Feb;73(2):105-12.

PMID:
9074944
[PubMed - indexed for MEDLINE]
Free Article
6.

Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade.

Niederau C, Borchard F, Lüthen R, Niederau M.

Hepatogastroenterology. 1996 Nov-Dec;43(12):1442-53.

PMID:
8975946
[PubMed - indexed for MEDLINE]
7.

Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.

Hirata M, Hayashi I, Yoshimura K, Ishii K, Soma K, Ohwada T, Kakita A, Majima M.

Br J Pharmacol. 2002 Jan;135(1):29-36.

PMID:
11786477
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats.

Tachibana I, Shirohara H, Czako L, Akiyama T, Nakano S, Watanabe N, Hirohata Y, Otsuki M.

Pancreas. 1997 Mar;14(2):113-21.

PMID:
9057182
[PubMed - indexed for MEDLINE]
9.

CCK-A receptor induction and P38 and NF-kappaB activation in acute pancreatitis.

Samuel I, Zaheer S, Nelson JJ, Yorek MA, Zaheer A.

Pancreatology. 2004;4(1):49-56. Epub 2004 Feb 26.

PMID:
14988658
[PubMed - indexed for MEDLINE]
10.

[Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].

Kobayashi M, Shinagawa K, Sugiura M, Nagasawa T, Akahane M, Ajisawa Y.

Nihon Yakurigaku Zasshi. 1996 Apr;107(4):183-95. Japanese.

PMID:
8690301
[PubMed - indexed for MEDLINE]
11.

Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. I. Bile duct obstruction with and without pancreatic duct obstruction.

Murayama KM, Samuel I, Toriumi Y, Solomon TE, Turkelson CM, Joehl RJ.

J Surg Res. 1993 Feb;54(2):126-31.

PMID:
7683071
[PubMed - indexed for MEDLINE]
12.

Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.

Varga G, Kisfalvi K, D'Amato M, Scarpignato C.

J Physiol Paris. 1997 May-Oct;91(3-5):257-64.

PMID:
9403804
[PubMed - indexed for MEDLINE]
13.

Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.

Moon SJ, An JM, Kim J, Lee SI, Ahn W, Kim KH, Seo JT.

Eur J Pharmacol. 2004 Nov 28;505(1-3):61-6.

PMID:
15556137
[PubMed - indexed for MEDLINE]
14.

The anti-inflammatory effect of methylprednisolone occurs down-stream of nuclear factor-kappaB DNA binding in acute pancreatitis.

Rakonczay Z Jr, Duda E, Kaszaki J, Iványi B, Boros I, Lonovics J, Takács T.

Eur J Pharmacol. 2003 Mar 19;464(2-3):217-27.

PMID:
12620516
[PubMed - indexed for MEDLINE]
15.

Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats.

Seo SW, Jung WS, Piao TG, Hong SH, Yun KJ, Park RK, Shin MK, Song HJ, Park SJ.

World J Gastroenterol. 2007 Apr 28;13(16):2298-304.

PMID:
17511027
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Role of cholecystokinin-A (CCK-A) receptor in pancreatic regeneration after pancreatic duct occlusion: a study in rats lacking CCK-A receptor gene expression.

Miyasaka K, Ohta M, Tateishi K, Jimi A, Funakoshi A.

Pancreas. 1998 Mar;16(2):114-23.

PMID:
9510132
[PubMed - indexed for MEDLINE]
17.

The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.

Axelson J, Fan BG, Ohlsson B, Rehfeld J, Ekelund M, Ihse I.

Int J Pancreatol. 1996 Oct;20(2):109-18.

PMID:
8968866
[PubMed - indexed for MEDLINE]
18.

Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. II. Pancreatic duct obstruction with and without bile duct obstruction.

Toriumi Y, Samuel I, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ.

J Surg Res. 1993 Feb;54(2):132-5.

PMID:
8479170
[PubMed - indexed for MEDLINE]
19.

The effect of the CCK receptor antagonist CR 1409 on bile reflux pancreatitis in the opossum.

Larsen F, Schlarman D, Andrus CC, Kaminski DL.

Pancreas. 1991 May;6(3):291-7.

PMID:
1713673
[PubMed - indexed for MEDLINE]
20.

Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.

Toriumi Y, Samuel I, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ.

J Lab Clin Med. 1993 Oct;122(4):450-4.

PMID:
8228560
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk